{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:01:01Z","timestamp":1789563661402,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/eurheartj\/ehx162","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T12:10:07Z","timestamp":1489493407000},"page":"2264-2276","source":"Crossref","is-referenced-by-count":128,"title":["Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial"],"prefix":"10.1093","volume":"38","author":[{"given":"Nobuhisa","family":"Hagiwara","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erisa","family":"Kawada-Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Koyanagi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Arashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Center, Saisei-Kai Kumamoto Hospital, 5-3-1 Chikami, Minami-ku, Kumamoto-shi, Kumamoto 861-4193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tobaru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu-shi, Tokyo 183-0003, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu-shi, Tokyo 183-8524, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu-shi, Shizuoka 430-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Endoh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saisei-Kai Kurihashi Hospital, 714-6 Kouemon, Kuki-shi, Saitama 349-1105, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nishiarai Heart Center, 1-12-8, Nishiarai-honcho, Adachi-Ku, Tokyo 123-0845, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center of Sendai, 1-6-12 Izumichuo, Izumi-ku, Sendai-shi, Miyagi 981-3133, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of General and Community Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Institute of Japan, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"key\n\t\t\t\t20180222014202_ehx162-B1","first-page":"1383","article-title":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.838466","article-title":"Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals","volume":"120","author":"Waters","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B7","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63(25\u2009Pt B)","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B8","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/VHRM.S5551","article-title":"Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals","volume":"5","author":"Saito","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/eurheartj\/ehs271","article-title":"Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion","volume":"34","author":"Zheng","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)","volume":"54","author":"Hiro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B13","doi-asserted-by":"crossref","first-page":"50k","DOI":"10.1016\/S0002-9149(02)02970-3","article-title":"Combination therapy for dyslipidemia: safety and regulatory considerations","volume":"90","author":"Davidson","year":"2002","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B14","doi-asserted-by":"crossref","first-page":"e000028.","DOI":"10.1161\/JAHA.112.000028","article-title":"Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy","volume":"2","author":"Raal","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of intestinal cholesterol absorption by ezetimibe in humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ahj.2004.10.001","article-title":"A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry","volume":"150","author":"Kasanuki","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehp101","article-title":"Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)","volume":"30","author":"Kasanuki","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.amjcard.2007.01.024","article-title":"Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program)","volume":"99","author":"Nagashima","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jjcc.2016.05.002","article-title":"Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER)","volume":"69","author":"Kawada-Watanabe","year":"2017","journal-title":"J Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2005.11.031","article-title":"Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese","volume":"97","author":"Sakamoto","year":"2006","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B24","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B25","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/CIR.0000000000000134","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B26","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B29","doi-asserted-by":"crossref","first-page":"f2610.","DOI":"10.1136\/bmj.f2610","article-title":"Risk of incident diabetes among patients treated with statins: population based study","volume":"346","author":"Carter","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B30","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.115.021168","article-title":"Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery","volume":"133","author":"Bangalore","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.06.026","article-title":"New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism","volume":"203","author":"Calpe-Berdiel","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B35","doi-asserted-by":"crossref","first-page":"i1246","DOI":"10.1136\/bmj.i1246","article-title":"Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)","volume":"353","author":"Ramsden","year":"2016","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamainternmed.2016.2751","article-title":"Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic heart disease taking statin treatment","volume":"176","author":"Leibowitz","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B37","doi-asserted-by":"crossref","first-page":"499.","DOI":"10.1007\/s11883-015-0499-4","article-title":"Targeting PCSK9 for therapeutic gains","volume":"17","author":"Shapiro","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2015.11.015","article-title":"Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial","volume":"173","author":"Sabatine","year":"2016","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B39","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.296.17.2105","article-title":"Statin therapy and risks for death and hospitalization in chronic heart failure","volume":"296","author":"Go","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.106.625574","article-title":"Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study","volume":"115","author":"Khush","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B41","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B42","first-page":"53","article-title":"Appropriateness of percutaneous coronary intervention","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180222014202_ehx162-B43","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Bonaa","year":"2016","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/29\/2264\/24120486\/ehx162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T06:42:14Z","timestamp":1519281734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/38\/29\/2264\/3738808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":43,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2017,4,18]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx162","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8,1]]},"published":{"date-parts":[[2017,4,18]]}}}